TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05819138: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Sponsor: University of Colorado, Denver · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

4 Active Trials

Excess Burn Exposure

$12,681,736

Rescue Site Savings

+$8,391,632

Unlock Full NCT05819138 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05819138 Rescue Dossier →